Details of issuance or disposal
Monthly exercise status of the Series 70 and Series 71 share acquisition rights issued through a third-party allotment (with exercise-price adjustment provisions)
Shares delivered during the month covered: 4,300,000 shares (4,300,000 new shares and 0 transferred treasury shares)
The lower thin line represents the existing number of shares to which these shares will be added.
Exercise ratio for exercise restrictions: 5.4% (4,300,000 shares delivered / 80,247,210 listed shares as of the payment date for the issuance)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status of the Series 70 and Series 71 share acquisition rights issued through a third-party allotment (with exercise-price adjustment provisions) |
| Number of shares to be issued or disposed of | Shares delivered during the month covered: 4,300,000 shares (4,300,000 new shares and 0 transferred treasury shares) |
| Intended allottee | EVO FUND (Series 70 and Series 71 share acquisition rights) |
| Dilution Rate | Exercise ratio for exercise restrictions: 5.4% (4,300,000 shares delivered / 80,247,210 listed shares as of the payment date for the issuance) |
| Total number of issued shares | 80,247,210 shares (as of 2 September 2026; 91,319 treasury shares) → Not disclosed |
| Exercise price | Exercise prices during the month covered were ¥61, ¥60, ¥59, ¥58, ¥57, ¥56, ¥53 and ¥55. An exercise-price adjustment provision applies. The lower limit of the adjustment is Not disclosed. |
| Number of Stock Acquisition Rights | Series 70: 480,000 units issued; 480,000 units unexercised as of 2 September 2026; 437,000 units unexercised as of the end of September 2026 |
| Procedures under the Corporate Code of Conduct | The filing states the status of compliance with exercise restrictions under the Tokyo Stock Exchange's listing regulations and other applicable rules. |
| Most recent equity financing | Announced on 17 August 2026: issuance through a third-party allotment of the Series 70 and Series 71 share acquisition rights (with exercise-price adjustment provisions) (the issue price and amount are Not disclosed in this document) |
Items this document does not state (19)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status. The company stated that it omitted disclosure of the monthly exercise status for the Series 71 share acquisition rights because they cannot be exercised until the company instructs the holder to begin exercising them.